Focus:
We've been discussing JDSA....Closed up slightly...Still displaying strength however...observe for continued footing at .50 where it held daylong yesterday.....Recall ceo buying 1.8mil shares...
APPG late day pickup of interest....Recently discussed as potential rebound candidate....taking shape..
ORGS also seeing a late day pickup...Extending a recent run this week....
| etailed Quote for ORGENESIS INC (ORGS) | |
Recent NBT Equities report may be having something to do with the recent pickup...
| Orgenesis (ORGS): New diabetes treatment would turn liver cells into insulin-producers When pancreatic islet allo-transplantation therapy was first introduced, it provided hope for countless diabetics tired of daily insulin injections. While the technology has delivered on much of its promise, Tel Aviv-based regenerative medicine firm Orgenesis is currently developing a treatment of its own, that it claims addresses much of the shortcomings of islet therapy. In a nutshell, its approach involves converting the patient's own liver cells into cells that produce insulin.
| ||
| 9:00 AM | Scott Carmer Named as CEO of Orgenesis North America - Marketwired | |
| ||
| 8:40 AM | Orgenesis Signs Agreement With MaSTherCell to Scale Manufacturing of Insulin-Producing Liver Cells to Combat Diabetes - Marketwired | |
| ||
| 8:31 AM | Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research -Marketwired | |
| ||
| 2:17 PM | Orgenesis Awarded Maryland Stem Cell Research Fund Grant - Marketwired | |
ERBB my mover yesterday...no news..
Notable earnings before today's open: BIG
Analyst notes: $SSYS started with "buy" and $SWKS target raised.
3 Biotech Stocks Under $10 in Breakout Territory
These under-$10 biotech stocks are within range of triggering breakout trades.
| QQQWall Street Breakfast: Google Developing Delivery Drone Fleet by Wall Street Breakfast
| |||||||||||
|
No comments:
Post a Comment